Search research articles
Contact Us
Filters
Showing results (411-420 of 524) with videos related to
Page
of 53
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T Chang, Alexander Penson, Neil B Desai, et al.
Science Translational Medicine
|
June 17, 2026
Clinicogenomic analysis of <i>EGFR</i>-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation
Alexandria Dymun, Mark Y Jeng, Arielle Elkrief, et al.
Cancer Discovery
|
April 19, 2026
A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception
Monte M Winslow, Mohamed A Ahmed, Christine D Berg, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 10, 2025
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS
Bingnan Zhang, Laura Alder, Samuel Rosner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 26, 2020
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer
Adam J Schoenfeld, Chai Bandlamudi, Jessica A Lavery, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Inference of single cell profiles from histology stains with the Single-Cell omics from Histology Analysis Framework (SCHAF)
Charles Comiter, Eeshit Dhaval Vaishnav, Metamia Ciampricotti, et al.
JTO Clinical and Research Reports
|
October 24, 2022
BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study
Quincy Chu, Natasha B Leighl, Veerle Surmont, et al.
The Lancet. Oncology
|
December 10, 2016
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Charles M Rudin, M Catherine Pietanza, Todd M Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies
Jonas Willmann, Edward Christopher Dee, Lizza E L Hendriks, et al.
Molecular Cancer Research : MCR
|
August 29, 2013
The twist box domain is required for Twist1-induced prostate cancer metastasis
Rajendra P Gajula, Sivarajan T Chettiar, Russell D Williams, et al.
Page
of 53
Search research articles
Search
Showing results (411-420 of 524) with videos related to
Sort By:
Page
of 53
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 29, 2017
Small-Cell Carcinomas of the Bladder and Lung Are Characterized by a Convergent but Distinct Pathogenesis
Matthew T Chang, Alexander Penson, Neil B Desai, et al.
Science Translational Medicine
|
June 17, 2026
Clinicogenomic analysis of <i>EGFR</i>-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation
Alexandria Dymun, Mark Y Jeng, Arielle Elkrief, et al.
Cancer Discovery
|
April 19, 2026
A Roadmap to Transform Lung Cancer Outcomes: Priorities in Biology, Therapeutic Innovation, Early Detection, Prevention and Interception
Monte M Winslow, Mohamed A Ahmed, Christine D Berg, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 10, 2025
A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS
Bingnan Zhang, Laura Alder, Samuel Rosner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 26, 2020
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung Cancer
Adam J Schoenfeld, Chai Bandlamudi, Jessica A Lavery, et al.
Biorxiv : the Preprint Server for Biology
|
March 30, 2023
Inference of single cell profiles from histology stains with the Single-Cell omics from Histology Analysis Framework (SCHAF)
Charles Comiter, Eeshit Dhaval Vaishnav, Metamia Ciampricotti, et al.
JTO Clinical and Research Reports
|
October 24, 2022
BMS-986012, an Anti-Fucosyl-GM1 Monoclonal Antibody as Monotherapy or in Combination With Nivolumab in Relapsed/Refractory SCLC: Results From a First-in-Human Phase 1/2 Study
Quincy Chu, Natasha B Leighl, Veerle Surmont, et al.
The Lancet. Oncology
|
December 10, 2016
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study
Charles M Rudin, M Catherine Pietanza, Todd M Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 5, 2026
Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies
Jonas Willmann, Edward Christopher Dee, Lizza E L Hendriks, et al.
Molecular Cancer Research : MCR
|
August 29, 2013
The twist box domain is required for Twist1-induced prostate cancer metastasis
Rajendra P Gajula, Sivarajan T Chettiar, Russell D Williams, et al.
Page
of 53